News

Dermatology Advisor17h
Zoryve Foam 0.3% Approved for Plaque Psoriasis of the Scalp, Body
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and ...
Rheumatology Advisor20h
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.